Illustrated medicinal herbs in a mortar beside tea, capsules, an amber bottle and a botanical notebook.

Traditional Remedies and Modern Supplements: When Are They the Same Treatment?

A supplement can come from an old medicinal plant and still be a substantially different treatment. The species may have changed. A leaf can replace a seed, an extract can replace a tea, or an isolated compound can replace a food. The condition being treated may change as well.

Historical use is worth investigating because it tells us what people observed and considered useful. To connect it to a modern product, follow the preparation and the practical question through time. A familiar plant name is only the beginning.

What needs to match?

Before treating an old use as evidence for a supplement, compare six things:

What to compare The question to ask
Identity Is it the same species and the same plant part?
Preparation Was it eaten, brewed, powdered, extracted or combined with other ingredients?
Route Was it swallowed, inhaled or applied to skin?
Intended use Was the aim the same symptom or health outcome?
Amount and duration Do we know how much was used and for how long?
Population Were the users comparable to the people in the study?

A mismatch identifies a connection that still needs testing. An unknown amount should stay unknown; filling it in with a modern capsule dose would create a treatment history that the source never supplied.

Geography shapes which plants were available and which uses were recorded. Echinacea is native to North America; saffron appears in Persian medical writing; ginkgo has a history in Chinese medicine. Those are different starting points, not one global tradition. A plant later sold across borders may arrive as a new extract, for a new purpose, to people with different diets or medical care. The historical account cannot answer those changed questions by itself. NCCIH on echinacea[1] · Saffron in Avicenna's Canon[2] · NCCIH on ginkgo[3]

Research also develops unevenly. Some traditional preparations have been tested directly, while others have only laboratory work, a study of a different extract, or no comparable human trial. That leaves a gap in knowledge; it does not show that every old use works or that an untested use fails. It also explains why a supplement promoted internationally can become popular before evidence catches up with the exact product. “Asian medicine” and “Western medicine” are too broad to describe these different practices or the researchers working in each region today.

A historical name or use can hide a different treatment

Bacopa and the name brahmi

Brahmi can refer to Bacopa monnieri or Centella asiatica. An experimental study explicitly identifies both uses of the name[4]. The Latin name therefore matters even before you compare extracts.

Bacopa's memory tradition does have a relatively close modern comparison. In Calabrese's placebo-controlled study[5], a bacopa extract made to a stated chemical specification improved delayed word recall after 12 weeks, while several other thinking measures did not change. That supports a narrow finding for the tested plant and preparation. It cannot transfer automatically to a different plant sold under the same common name.

Ginkgo and the condition being treated

NCCIH describes historical Chinese uses of ginkgo[3] including cough and diarrhea. Modern ginkgo supplements for memory usually contain leaf extract. A claim that ginkgo has a long medicinal history therefore leaves an essential question unanswered: a history of which use?

The large Ginkgo Evaluation of Memory trial[6] did not find that its leaf extract prevented dementia in older adults. That result challenges a modern prevention claim. It does not test the older respiratory or intestinal uses, and those older uses cannot supply the missing dementia-prevention evidence.

Saffron and the mood question

A review of Avicenna's Canon[2] describes saffron among remedies associated with mood and sleep in Persian medicine. That historical account helped frame a modern question, but it did not define depression using today's diagnostic criteria. A six-week placebo-controlled trial[7] tested 30 mg a day of a saffron-stigma preparation in 40 adults with mild to moderate major depression and found better clinician-rated scores. The trial is a modern test of a related use, not proof that culinary threads or every saffron supplement has the same effect. Our saffron history and mood guide follows that connection in detail.

Echinacea and cold remedies

NCCIH records North American Indigenous uses of echinacea[1] for respiratory infections and other problems. Today, echinacea products are marketed internationally for colds. The Cochrane review[8] found that trials used different species, plant parts and preparations; a possible small prevention signal does not establish that a different bottle shortens an illness once it begins. The history inspired a recognizable modern question, but the product and timing still have to match the evidence.

A food and an isolated ingredient need separate evidence

Natto and nattokinase

Natto is a Japanese fermented-soy food. Sumi's 1987 report[9] identified a fibrin-degrading enzyme in it, now sold as nattokinase. Finding that enzyme was a new biochemical observation about an existing food.

The claim changes when a nattokinase supplement promises that swallowing the isolated enzyme will prevent cardiovascular disease. A three-year placebo-controlled trial[10] in 265 adults found no advantage on its measured artery changes. Food history, enzyme activity in a laboratory and improved health from an oral capsule are separate pieces of evidence.

Turmeric and concentrated curcumin

NCCIH describes turmeric's use[11] in several Asian medical traditions, as well as in food. A modern turmeric or curcumin product may isolate curcuminoids or change how much is absorbed. That gives researchers a defined intervention to test, but a result for the concentrated preparation cannot be assigned to a meal containing turmeric—or vice versa. The old use supplies a research lead; the current product needs its own amount, formulation and outcome evidence.

Extraction creates a similar question. A tea contains whatever its brewing process releases into water; a concentrated extract depends on its starting material, solvent and manufacturing process. Matching the plant's name or the total milligrams does not establish that the resulting mixtures are equivalent.

A useful observation can survive an incorrect explanation

People can notice that a treatment helps before knowing why. The later discovery of a mechanism does not erase the observation, and the observation does not establish every explanation offered for it.

The history of beriberi illustrates this well. In his 1929 Nobel lecture[12], Frederick Hopkins described the shift from interpreting rice-related findings as neutralizing a poison to recognizing a missing dietary substance. Thiamin deficiency now supplies a biological explanation for beriberi.

With herbal studies, the connection is often less complete. A trial may find a lower symptom score without establishing which constituent caused it or which pathway mattered. Even an accompanying hormone change cannot by itself show that the hormone change caused the symptom benefit. Observing two changes together leaves that causal question open.

This gives traditional explanations room to be examined without treating them as established biochemistry. A researcher can test an outcome associated with rejuvenation or vitality while recognizing that a short trial does not measure everything those categories meant.

Recognized herbal uses have preparation limits

Senna and ivy leaf

Some herbal medicines have evidence for a defined use beyond a history of use. The European Medicines Agency's senna assessment[13] recognizes specified preparations for short-term occasional constipation. Its ivy-leaf assessment[14] recognizes specified extracts to help bring up mucus when you have a cough. Neither conclusion extends automatically to an unspecified cleansing blend or a raw plant.

Valerian and the preparation assessed

Valerian shows why two official summaries can sound different. The US National Center for Complementary and Integrative Health finds inconsistent sleep evidence[15], while the European Medicines Agency recognizes certain root extracts made using ethanol[16] for mild nervous tension and sleep disorders. Ethanol is the alcohol used during extraction; it need not remain in the finished dry extract. The assessed preparations and uses matter when you compare those conclusions with a tea or capsule.

A familiar food name can conceal a different plant part

Rhubarb root and culinary stalk

The EMA's rhubarb assessment[17] concerns specified medicinal roots used as laxatives. Culinary stalks are a different material. A separate menopause trial[18] tested an extract of another species, Rheum rhaponticum. Neither the food name nor the word rhubarb makes these interventions interchangeable.

A modern study can lose its standing

The prominent 2024 apple-cider-vinegar weight-loss trial was retracted in 2025[19]. That removes this paper as support for the claim. An older reputation for vinegar cannot repair an unreliable modern experiment.

The bottom line

Start with the source behind the history. A named text, institutional account or documented community practice is more useful than an unsupported age claim. Then identify what the source actually records: a preparation, a recommended use, an observed response or an explanation. Those are different kinds of information.

Next, compare the modern study with the product. Look for the botanical name, plant part, extract details and stated amount. Read the actual outcome: recalling words, reporting less stress and developing fewer illnesses are different results.

Finally, ask what the history adds. It may explain why a plant was selected for investigation, reveal a preparation that researchers have overlooked or support continuity in a practical use. It cannot fill a missing controlled comparison or establish the safety of a new concentration. You can respect the observation and still require evidence for the product you are considering.

Help us improve this article

Spotted an error or found a source we should consider? Tell us which part of this article needs another look and include a link if you have one. Please leave out personal health details and lab results; we can’t answer individual medical questions.

Email us directly

References

  1. NCCIH on echinacea ↩
  2. Saffron in Avicenna's Canon ↩
  3. NCCIH on ginkgo ↩
  4. experimental study explicitly identifies both uses of the name ↩
  5. Calabrese's placebo-controlled study ↩
  6. Ginkgo Evaluation of Memory trial ↩
  7. six-week placebo-controlled trial ↩
  8. Cochrane review ↩
  9. Sumi's 1987 report ↩
  10. three-year placebo-controlled trial ↩
  11. NCCIH describes turmeric's use ↩
  12. 1929 Nobel lecture ↩
  13. European Medicines Agency's senna assessment ↩
  14. ivy-leaf assessment ↩
  15. US National Center for Complementary and Integrative Health finds inconsistent sleep evidence ↩
  16. European Medicines Agency recognizes certain root extracts made using ethanol ↩
  17. EMA's rhubarb assessment ↩
  18. menopause trial ↩
  19. retracted in 2025 ↩